open access

Vol 6, No 3 (2013)
REVIEWS
Get Citation

The latest news on molecular basis of blood groups presented during the 23rd Regional Congress of the International Society of Blood Transfusion in Amsterdam

Agnieszka Orzińska, Katarzyna Guz, Ewa Brojer
Journal of Transfusion Medicine 2013;6(3):101-104.

open access

Vol 6, No 3 (2013)
REVIEWS

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

The latest news on molecular basis of blood groups presented during the 23rd Regional Congress of the International Society of Blood Transfusion in Amsterdam

Journal

Journal of Transfusion Medicine

Issue

Vol 6, No 3 (2013)

Pages

101-104

Bibliographic record

Journal of Transfusion Medicine 2013;6(3):101-104.

Authors

Agnieszka Orzińska
Katarzyna Guz
Ewa Brojer

References (16)
  1. Storry J, Joud M, et al. Kronberg Christophersen M. Intergrative genomics identities SMIM1 as the locus of a novel erythrocyte membrane protein and the Vel blood group system. Vox Sang. 2013; 105(supl. 1): 29.
  2. Sussman LN, Miller EB. New blood factor: Vel. Rev Hematol. 1952; 7(3): 368–371.
  3. Haer-Wigman L, de Haas M, van der Schoot C. The immune response to the Vel antigen is HLA-class II DRB1*11 restricted. Vox Sang. 2013; 105(supl. 1): 29.
  4. Weinstock C, von Zabern I, Hochsmann B, et al. CD59 defines a new blood group system. Vox Sang. 2013; 105(supl. 1): 29–30.
  5. Karamatic Crew V, Thornton N, Bullocck T, et al. Serological and molecular characterization of DOLC, a novel high incidence antigen in the Dombrock blood group system. Vox Sang. 2013; 105(supl. 1): 30.
  6. Blancher A. Evolution of the ABO supergene family. Vox Sang. 2013; 105(supl. 1): 43.
  7. Cai X, Jin S, Liu X, et al. Molecular genetic analysis of ABO blood group variations reveals 29 novel ABO subgroup alleles. Vox Sang. 2013; 105(supl. 1): 43–44.
  8. Ogasawara K, Isa K, Tsuneyama H, et al. Molecular basis for Japanese individuals with B m and A m . Vox Sang. 2013; 105(supl. 1): 44.
  9. Thuresson B, Hellberg A, Olsson M. Disruption of a binding site for the erythroid transcription factor GATA-1 in intron 1 of the ABO gene in A m and B m subgroup samples. Vox Sang. 2013; 105(supl. 1): 44.
  10. Karolak E, Waśniowska K, Grodecka M, et al. Frequency of Duffy gene polymorphism in Polish population studied by high resolution melting (HRM) analysis. Vox Sang. 2013; 105(supl. 1): 198.
  11. Michalewska B, Hellberg A, Pelc-Kłopotowska M, et al. Genetic basis of cis-AB in a woman from Poland where the phenotype was first described. Vox Sang. 2013; 105(supl. 1): 228.
  12. Mifsud NA, Watt JM, Condon JA, et al. A novel cis-AB variant allele arising from a nucleotide substitution A796C in the B transferase gene. Transfusion. 2000; 40(10): 1276–1277.
  13. Haer-Wigman L, Soussan A, de Ha. van der Schoot C. Molecular analysis of immunized Lan- or Jra- negative patients and validation of genotyping assays to screen blood donors for Lan- or Jra-negativity. Vox Sang. 2013; 105(supl. 1): 229.
  14. Yamamuro Y, Isa K, Ogasawara K, et al. The new mutation of ABCB6 gene i Lan- Japanese. Vox Sang. 2013; 105(supl.1): 230.
  15. Tobita R, Kaito S, Osabe T, et al. Genetic analysis of the Jr(a-) in Japanese people. Vox Sang. 2013; 105(supl. 1): 230.
  16. Tanaka M, Kamada I, Takahashi J, et al. Novel Jr null allele in the Japanese population. Vox Sang. 2013; 105(supl. 1): 230.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl